References
- Chung H, Kim J, Um JY, Kwon IC, Jeong SY. (2002). Self-assembled “nanocubicle” as a carrier for peroral insulin delivery. Diabetologia, 45, 448–451.
- Kim MJ, Kim HK. (2006). Anti-diabetic effects of electrolyzed reduced water in streptozotocin-induced and genetic diabetic mice. Life Sci, 79, 2288–2292.
- Lifschitz MD, Garcia JA, Earley LE. (1973). Effect of passive water absorption on transepithelial movement of extracellular solutes in rat intestine. Kidney Int, 4, 362–368.
- Lin Y-H, Chen C-T, Liang H-F, Kulkarni AR, Lee PW, Chen CH, Sung HW. (2007). Novel nanoparticles for oral insulin delivery via the paracellular pathway. Nanotechnology, 18, 1–11.
- Malecki MT, Klupa T. (2005). Type 2 diabetes mellitus: from genes to disease. Pharmacol Rep, 57 Suppl, 20–32.
- Peddyreddy MK, Rao KR. (2006). Peripheral and centrally mediated effects of insulin on small intestinal transit in healthy mice. Clin Exp Pharmacol Physiol, 33, 633–636.
- Reddy PM, Dkhar SA, Subramanian R. (2006). Effect of insulin on small intestinal transit in normal mice is independent of blood glucose level. BMC Pharmacol, 6, 4.
- Sharpe K, Ward L, Cichero J, Sopade P, Halley P. (2007). Thickened fluids and water absorption in rats and humans. Dysphagia, 22, 193–203.
- Wapnir RA, Sia MC, Fisher SE. (1996). Enhancement of intestinal water absorption and sodium transport by glycerol in rats. J Appl Physiol, 81, 2523–2527.
- Wong TW. (2009). Chitosan and its use in design of insulin delivery system. Recent Pat Drug Deliv Formul, 3, 8–25.
- Wong TW. (2010). Design of oral insulin delivery systems. J Drug Target, 18, 79–92.